FAQs about CDC’s 6|18 Initiative
The CDC’s 6|18 Initiative was developed to provide health care purchasers, payers, and providers with rigorous evidence about high-burden health conditions and associated evidence-based interventions. It is designed to inform decisionmaking around strategies to improve coverage, access, utilization, and quality and where those strategies can have the greatest impact on improving outcomes and controlling costs.
Following are frequently asked questions about CDC’s 6|18 Initiative:
Why is the 6|18 Initiative a CDC priority for prevention and health care delivery?
What are the common conditions and interventions and how were they selected?
- They affect large numbers of people;
- They are associated with high health care costs;
- Evidence-based interventions are known to prevent or control these conditions in a short time horizon (less than five years); and
- The evidence-based interventions can be implemented by the health care delivery system –health care purchasers, payers, and providers.
The Initiative specifies interventions associated with each of the six conditions that health care purchasers, payers, or providers can implement.
Who is leading the 6|18 Initiative, and how are other partners involved in 6│18 implementation?
How does CDC's 6|18 Initiative fit into the “Three Buckets of Prevention” framework?
Which states/communities are participating in CDC's 6|18 Initiative?
CDC, CHCS and its partners are working with four rounds of Medicaid and public health 6|18 teams. The first round of states participating in this effort are: Colorado, Georgia, Louisiana, Massachusetts, Michigan, Minnesota, New York, Rhode Island, and South Carolina. The second round of teams participating in this effort include six states and one local entity: Alaska, Maryland, Nevada, North Carolina, Texas and Utah, the District of Columbia, and Los Angeles County. The third round of teams participating in this effort include 17 states and 1 U.S. territory: Arkansas, California, Connecticut, Indiana, Kansas, Kentucky, Missouri, Montana, Nebraska, New Hampshire, New Jersey, Pennsylvania, Rhode Island, South Dakota, Tennessee, Virginia, Wyoming, and the Commonwealth of the Northern Mariana Islands. The fourth round of teams participating in this effort include 16 states and three U.S. territories:Colorado, Connecticut, Illinois, Kansas, Kentucky, Michigan, Missouri, Nebraska, Nevada, New Mexico, North Carolina, North Dakota, Oklahoma, Texas, Virginia, Wyoming, the Commonwealth of Northern Mariana Islands, Guam, and the U.S. Virgin Islands.
How might other states/entities go about bringing together health care payers, purchasers, public health departments, and providers to enhance the coverage, access, utilization, and quality of cost-effective prevention practices, using the 6|18 model?
Explore the information and resources in this website to learn more about opportunities for implementing CDC’s 6|18 Initiative interventions. In addition, ASTHO developed a “Getting Started” guidance tool for use by state Medicaid and public health agency staff to help them determine whether their agencies want to form a 6|18 team and to help them consider how their state will implement one or more of the 6|18 evidence-based interventions. The tool’s purpose is to lay a foundation for success by helping potential state teams ensure that all aspects of the implementation process are considered. As part of this process, staff can use this tool to collect information on current programs, consider the 6|18 Initiative’s alignment with current health priorities and payment reform activities and goals, and identify important stakeholders with whom to engage.
Is there funding available to state Medicaid/public health teams to implement 6|18 interventions?
Do CHCS and CDC plan to engage with payers and purchasers beyond Medicaid as part of the 6|18 Initiative?
Will other common health conditions be added?
How is the 6|18 Initiative being evaluated? How are the 6|18 teams measuring health and cost outcomes?
CDC will work with health care purchasers (employers responsible for employee health and insurance coverage), payers (public and private health insurers), and providers (health systems, physicians, and providers of ancillary services) who are implementing the specific interventions to monitor the quantitative, qualitative, and health and cost impact changes that occur as a result of this initiative. CDC and implementing partners will broadly share these qualitative, quantitative, and impact changes, along with facilitators and barriers to adoption of these interventions, for others to consider implementing.